Astrana Health Stock Total Asset
| AMEHDelisted Stock | USD 34.07 0.34 0.99% |
Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.
Astrana |
Astrana Health Company Total Asset Analysis
Astrana Health's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Astrana Health Total Asset | 966.21 M |
Most of Astrana Health's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Astrana Health has a Total Asset of 966.21 M. This is 87.15% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The total asset for all United States stocks is 96.72% higher than that of the company.
Astrana Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in total asset category among its peers.
Astrana Fundamentals
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X | |||
| Price To Book | 3.12 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 1.33 B | |||
| Gross Profit | 199.48 M | |||
| EBITDA | 117.97 M | |||
| Net Income | 48.51 M | |||
| Cash And Equivalents | 273.71 M | |||
| Cash Per Share | 6.04 X | |||
| Total Debt | 229.36 M | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 2.49 X | |||
| Book Value Per Share | 12.74 X | |||
| Cash Flow From Operations | 133.87 M | |||
| Short Ratio | 17.16 X | |||
| Earnings Per Share | 1.04 X | |||
| Target Price | 46.56 | |||
| Number Of Employees | 1.36 K | |||
| Beta | 1.04 | |||
| Market Capitalization | 1.86 B | |||
| Total Asset | 966.21 M | |||
| Retained Earnings | 192.68 M | |||
| Working Capital | 287.81 M | |||
| Current Asset | 13.56 M | |||
| Current Liabilities | 7.43 M | |||
| Z Score | 7.27 | |||
| Net Asset | 966.21 M |
About Astrana Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |